Balchem Corporation Announces Dividend Declaration

Balchem Corporation (NASDAQ: BCPC) declared a dividend on its common stock in an announcement made on December 10, 2024. The decision was reached by the Company’s Board of Directors on December 9, 2024. The dividend amounts to $0.87 per share on the issued and outstanding Common Stock. The dividend is scheduled to be paid to stockholders of record as of December 26, 2024, with a payment date of January 17, 2025. This dividend signifies a 10.1% increase compared to the previous year’s annual dividend.

Ted Harris, the Chairman, President, and CEO of Balchem, expressed satisfaction with the ongoing commitment to an annual dividend by the company. He highlighted that this dividend marks the sixteenth consecutive increase in the annual dividend. Harris emphasized that this decision reflects the company’s consistent outstanding financial performance and the Board’s ongoing confidence in the long-term strategies of Balchem.

Balchem Corporation, headquartered in Montvale, New Jersey, focuses on developing, manufacturing, and marketing specialty ingredients aimed at enhancing health and well-being across various industries globally. The company operates through three primary business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. These segments provide solutions for food and beverage, animal health, and micronutrient agricultural markets.

In light of these developments, Balchem has issued forward-looking statements that entail risks and uncertainties. The company underlines that while they believe in their future outlook, actual results may vary due to various factors. Balchem encourages shareholders and investors to review the Annual Report on Form 10-K for the year ended December 31, 2023, and other SEC filings for a comprehensive understanding of the risks involved. Balchem states that they bear no obligation to update or revise any forward-looking statements at a later date.

For further information, Jacqueline Yarmolowicz of Balchem Corporation can be contacted at 845-326-5600.

The referenced press release in its entirety is available on the Company’s site for interested parties. Readers are encouraged to peruse the official document for detailed information regarding this announcement.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Balchem’s 8K filing here.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.